Ligand Pharmaceuticals Inc (NAS:LGND)
$ 122.55 -1.78 (-1.43%) Market Cap: 2.32 Bil Enterprise Value: 2.10 Bil PE Ratio: 48.82 PB Ratio: 2.73 GF Score: 75/100

Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 06:35PM GMT
Release Date Price: $61.18 (+3.71%)
Operator

Thank you for standing by, and welcome to the Ligand Pharmaceuticals conference call. (Operator Instructions) Thank you.

I would now like to turn the call over to our host, John Higgins. You may begin.

John L. Higgins
Ligand Pharmaceuticals Incorporated - CEO & Executive Director

Thank you. I appreciate the introduction, and Balaji and Barclays, want to acknowledge the participation in the conference. We appreciate the flexibility for people to dial in. We have a presentation. Matt Foehr and I are going to walk through our slides we posted to our website today. The way the mechanics work, we'll call out the slide number to help guide the listener, then we'll go to Q&A. Balaji has some questions, we'll do in a fireside chat. Matt Korenberg, our CFO, is also with us.

So I'm going to go through our presentation. Again, it is on our website. We also issued a press release this morning, acknowledging this conference a bit today. The presentation, we're going to be talking about our business. As we see it now, we'll be making forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot